The announcement comes a day after Lupin said the US FDA had inspected its Nagpur injectable facility between September 8 and ...

Lupin has bagged the approval for Lenalidomide capsules. This drug is used in the treatment of Multiple Myeloma (MM). In an ...

Lupin shares have gained for eight consecutive trading sessions as of Tuesday's close. The last time the stock gained for ...

This comes just weeks after Lupin secured USFDA approval for its Risperidone Injectable, used to treat schizophrenia and ...

Lupin announced that it has received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for lenalidomide capsules.

Mumbai: Global pharma major Lupin Limited has announced that the company has received approval from the United States Food ...

Wide Open Agriculture (ASX: WOA) has received a five-tonne order for its lupin protein from Univar Solutions China for use in ...

Lupin Manufacturing Solutions has announced that Empagliflozin API, manufactured at its Vizag facility, has received CADIFA ...

The market may consolidate, but overall, the trend remains favourable for bulls. Below are some short-term trading ideas to ...

The market may remain consolidative with rangebound trading until the August high is decisively broken. Below are some ...

Global brokerage Investec upgraded Lupin to a ‘buy’ from the previous ‘hold’ and also lifted its price target by 8% to ₹2,265. The revised target implies a potential upside of about 14% from ...

Lupin shares trade at Rs 1,979.70, showing early reversal signs and poised to break the falling trend line above Rs 2,000.